Regular Article
ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology

https://doi.org/10.1006/jmcc.2000.1111Get rights and content

Abstract

G. J. Grover and K. A. Garlid. ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology. Journal of Molecular and Cellular Cardiology (2000) 32, 677–696. ATP-sensitive potassium channels (KATP) have been thought to be a mediator of cardioprotection for the last ten years. Significant progress has been made in learning the pharmacology of this channel as well as its molecular regulation with regard to cardioprotection. KATPopeners as a class protect ischemic/reperfused myocardium and appear to do so by conservation of energy. The reduced rate of ATP hydrolysis during ischemia exerted by these openers is not due to a cardioplegic effect and is independent of action potential shortening. Compounds have been synthesized which retain the cardioprotective effects of first generation KATPopeners, but are devoid of vasodilator and cardiac sarcolemmal potassium outward currents. These results suggest receptor or channel subtypes. Recent pharmacologic and molecular biology studies suggest the activation of mitochondrial KATPas the relevant cardioprotective site. Implications of these results for future drug discovery and preconditioning are discussed.

References (136)

  • A Noma

    ATP-regulated K+channels in cardiac muscle

    Nature

    (1983)
  • G Edwards et al.

    The pharmacology of ATP-sensitive potassium channels

    Annu Rev Pharmacol Toxicol

    (1993)
  • D Kim et al.

    Potassium channels in cardiac cells activated by arachidonic acid and phospholipids

    Science

    (1989)
  • G Kirsch et al.

    Coupling of ATP-sensitive K+channels to A1receptors by G proteins in rat ventricular myocytes

    Am J Physiol

    (1990)
  • W Coetzee et al.

    Effects of thiol-modifying agents on KATPchannels in guinea pig ventricular cells

    Am J Physiol

    (1995)
  • Z Ming et al.

    Beta 2-adrenergic dilation of resistance coronary vessels involves KATPchannels and nitric oxide in conscious dogs

    Circulation

    (1997)
  • A Spruce et al.

    Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane

    Nature

    (1985)
  • J de Weille et al.

    ATP-sensitive K+channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone

    Proc Natl Acad Sci USA

    (1998)
  • MJ Dunne et al.

    Interaction of diazoxide, tolbutamide and STP on nucleotide-dependent K+ channels in an insulin-secreting cell line

    J Membr Bio

    (1987)
  • FM Ashcroft et al.

    Glucose induces closure of single potassium channels in isolated rat pancreatic &bgr -cells

    Nature

    (1984)
  • MB Mitchell et al.

    Preconditioning of isolated rat heart is mediated by protein kinase C

    Circ Res

    (1995)
  • A D»Alonzo et al.

    Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration

    Cardiovasc Res

    (1992)
  • RM Shaw et al.

    Electrophyiosologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration

    Cardiovasc Res

    (1997)
  • S Shigamatsu et al.

    Anoxia-induced activation of ATP-sensitive K+channels in guinea pig ventricular cells and its modulation by glycolysis

    Cardiovasc Res

    (1997)
  • N Venkatesh et al.

    Sulfonylureas, ATP-sensitive K+loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle

    Circ Res

    (1991)
  • T Kondo et al.

    Glibenclamide attenuates peaked T wave in early phase of myocardial ischemia

    Cardiovasc Res

    (1996)
  • N Inagaki et al.

    Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor [see comments]

    Science

    (1995)
  • F Ashcroft

    Fresh insights into the interactions of drugs with ATP-sensitive K+channels

    ID Research Alert

    (1996)
  • L Philipson et al.

    Pas de deux or more: the sulfonylurea receptor and K+channels [comment]

    Science

    (1995)
  • G Wellman et al.

    ATP-sensitive potassium channels: molecular structure and therapeutic potential in smooth muscle

    ID Research Alert

    (1997)
  • A Spruce et al.

    Studies of the unitary properties of adenosine-5′-triphosphate-regulated potassium channels of frog skeletal muscle

    J Physiol (Lond)

    (1987)
  • M Hiraoka et al.

    Functional modulation of cardiac ATP-sensitive K+channels

    News Physiol Sci

    (1998)
  • K Hu et al.

    Protein kinase C activates ATP-sensitive K+current in human and rabbit ventricular myocytes

    Circ Res

    (1996)
  • W Jackson et al.

    Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels

    Am J Physiol

    (1993)
  • T Kleppisch et al.

    Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2receptors and cAMP-dependent protein kinase

    Proc Natl Acad Sci USA

    (1995)
  • TE Schackow et al.

    Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by &bgr -adrenergic stimulation

    J Physiol

    (1995)
  • A Babenko et al.

    Enhancement of the ATP-sensitive K+current by extracellular ATP in rat ventricular myocytes. Involvement of adenylyl cyclase-induced subsarcolemmal ATP depletion

    Circ Res

    (1997)
  • CB Wollheim et al.

    Activators of protein kinase C depolarize insulin-secreting cells by closing potassium channels

    EMBO J

    (1988)
  • W Cole et al.

    ATP-regulated K+channels protect the myocardium against ischemia/reperfusion damage

    Circ Res

    (1991)
  • K Atwal et al.

    Cardioselective anti-ischemic ATP-sensitive potassium channel openers

    J Med Chem

    (1993)
  • KD Garlid et al.

    Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive potassium channels: possible mechanism of cardioprotection

    Circ Res

    (1997)
  • K Lamping et al.

    Improved recovery of myocardial segmental function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine

    J Cardiovasc Pharmacol

    (1985)
  • GJ Grover et al.

    Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide

    J Pharmacol Exp Ther

    (1989)
  • GJ Grover et al.

    The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs

    Cardiovasc Drugs Ther

    (1990)
  • G Grover et al.

    Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides

    J Pharmacol Exp Ther

    (1991)
  • GJ Grover et al.

    Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891

    Eur J Pharmacol

    (1990)
  • CA Sargent et al.

    Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075

    J Cardiovasc Pharmacol

    (1993)
  • H Ohta et al.

    Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart

    Eur J Pharmacol

    (1991)
  • M Galinanes et al.

    Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia

    Cardiovasc Res

    (1992)
  • G Grover

    Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia

    J Cardiovasc Pharmacol

    (1994)
  • Cited by (0)

    f1

    Please address all correspondence to: Gary J. Grover, Ph.DMetabolic Diseases Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000, USA. Phone: +609 252-5139; Fax: +609 252-6609.

    View full text